#AAD24 roundup: Da­ta from Sanofi, Alu­mis, Gal­der­ma and more

Be­low are no­table up­dates from the Amer­i­can Acad­e­my of Der­ma­tol­ogy’s an­nu­al meet­ing over the week­end:

Sanofi amends tri­al pro­to­col

Sanofi has big plans for am­lite­limab …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER